IFNA1 and COVID-19: Although type-I interferon neutralization was detected in a subset of patients with IFN antigen reactivity, these samples did not fully account for the observed ISG heterogeneity or disease severity.<h4>Conclusions</h4>High ISG expression in COVID-19 defines a transcriptional endotype associated with systemic inflammation and innate immune activation.